Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Alemtuzumab
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --18件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬
2Alemtuzumab (already received BY alemtuzumab cohort between 1991 and 1994
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --1件: 46 💬
3Alemtuzumab 0.2 MG
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --2件: 65, 164 💬
4Alemtuzumab 0.3 MG
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --2件: 65, 164 💬
5Alemtuzumab 12 MG
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --1件: 13 💬
6Alemtuzumab 24 MG
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --1件: 13 💬
7Alemtuzumab and rituximab
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --1件: 60 💬
8Alemtuzumab GZ402673
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --1件: 13 💬
9Alemtuzumab immunotherapy
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --1件: 13 💬
10Alemtuzumab injection
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --1件: 13 💬
11Alemtuzumab, rituximab
(Campath, CAMPATH)		1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --1件: 63 💬
12Campath1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --3件: 49, 51, 60 💬
13Campath -1H----1件: 65 💬
14Campath 1H----4件: 60, 65, 164, 285 💬
15Campath, busulfan, clofarabine----1件: 326 💬
16Campath, chemo and/or TBI allo SCT----3件: 60, 62, 283 💬
17Campath, fludarabine, cyclophosphamide----2件: 65, 284 💬
18Campath-1H1件: Alemtuzumab1件: Alemtuzumab (Campath, CAMPATH) 💬 --6件: 19, 20, 60, 65, 234, 326 💬
19Cyclophosphamide,campath IH and TBI1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 60 💬
20Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
(Campath, CAMPATH)		----1件: 13 💬
21Natalizumab/natalizumab-sztn, alemtuzumab, ocrelizumab, rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, cladribine, ofatumumab, ublituximab-xiiy, ocrelizumab and hyaluronidase-ocsq
(Campath, CAMPATH)		1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
22Transplant preparative regimen OF alemtuzumab, fludarabine, thiotepa, and melphalan
(Campath, CAMPATH)		----2件: 65, 164 💬